New chief executive for Rabin Martin
August 20, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing jeffrey sturchio, rabin martin
US health consulting firm Rabin Martin has appointed Dr Jeffrey Sturchio as its new president and chief executive. Sturchio joined …
Reprieve for AstraZeneca as US drops drug investigation
August 19, 2014Sales and Marketing AstraZeneca, Brilinta, US, blood, justice, plato
The US Justice Department has pulled a controversial investigation into AstraZeneca’s pivotal clinical trial after finding no wrongdoing. The inquiry …
Sanofi and PATH launch large-scale malaria drug production
August 19, 2014Manufacturing and Production, Sales and Marketing Africa, Sanofi, acts, artemisinin, malaria, path
Sanofi and global health charity PATH have come together to launch a large-scale production line of malaria jab semisynthetic artemisinin …
New chief medical officer for TeamHealth
August 19, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing miles, snowden, teamhealth
Outsourced doctor staffing US firm TeamHealth Holdings has appointed Dr Miles Snowden as the company’s chief medical officer (CMO). Snowden …
Science will ‘lose out’ if Scotland chooses independence
August 18, 2014Research and Development, Sales and Marketing Conservative, Scotland, UK, george freeman, life sciences
The new minister for UK life sciences George Freeman has warned that independence from England “would damage Scotland’s edge in …
Top four cancer killer rates ‘fall by a third’
August 18, 2014Research and Development, Sales and Marketing CRUK, Cancer, bowel, charity, lung, prostate, research
Death rates for breast, bowel, lung and prostate cancer combined have fallen by almost a third in the last 20 …
FDA approves Biogen’s long-acting MS drug
August 18, 2014Sales and Marketing Avonex, Biogen, FDA, MS, Rebif, plegridy, tecfidera
Biogen Idec has racked up another approval over the weekend after its latest multiple sclerosis treatment Plegridy gained FDA backing. …
The end of salesmanship?
August 18, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, Rose, a bpi, all trials, evidence, gold acre, sales, salesmanship
Although my specialism for the last 35 years has been clinical research, I actually started in the pharmaceutical industry as …
Oxford BioMedica takes on executive position
August 18, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Oxford BioMedica, blake
Gene and cell therapy firm Oxford BioMedica has confirmed that non-executive director Dr Paul Blake has been appointed to the …
Charities ‘disappointed’ in NICE and Janssen
August 15, 2014Sales and Marketing Cancer, Janssen, NHS, NICE, Zytiga, prostate
The Institute of Cancer Research and Prostate Cancer UK are both urging NICE and Janssen to ‘get their act together’ …
Life hires principal writer from PAN
August 15, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Catriona Hampton, Life, Pan
Catriona Hampton has joined Life Healthcare Communications in Windsor, UK as a principal writer. Hampton who graduated in Immunology at …
SHL to exhibit at the 2014 PDA Conference in California, USA
August 15, 2014Sales and Marketing auto injector, pda 2014, shl event, shl pda 2014
The growth of the auto injector industry has been driven largely in part by the need to improve patient compliance …
InterMune stock jumps on suitor claims
August 14, 2014Sales and Marketing Boehringer, Esbriet, FDA, GSK, IPF, InterMune
Riding high of the success of its new lung drug Esbriet, InterMune has become the focus of some serious takeover …
Vertex ditches its once-stellar hep C drug
August 14, 2014Sales and Marketing Gilead, Incivek, Vertex, hep C, sovaldi
Vertex will stop selling its once-blockbuster hepatitis C drug in the US this autumn after being crushed by new therapies. …
Amgen cancer drug fails key test
August 14, 2014Sales and Marketing Amgen, Cancer, Kyprolis, myeloma
Amgen’s new rare cancer drug has failed in a late-stage trial just a year after the US biotech spent $10.4 …
New chief executive for Medivir
August 14, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Medivir, Niklas Prager
Niklas Prager has been named as the new president and chief executive of Sweden-based pharma firm Medivir. Starting in September, …
Pharma publisher confirms two hires
August 13, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Samedan, george underwood, pharmafile. pharmafocus, tom robinson
Samedan Pharmaceutical Publishers has appointed two editorial and production assistants to join Pharmafile and Pharmafocus. Tom Robinson (pictured right) joins Pharmafile …
NHS in Scotland deploys mobile healthcare
August 13, 2014Medical Communications, Sales and Marketing NHS, Safe Patient Systems, Scotland, digital, nhs scotland, tablets
Mobile healthcare firm Safe Patient Systems is partnering with NHS Greater Glasgow and Clyde (NHSGGC) to provide mobile healthcare services …
Pfizer teams up with Google-backed 23andMe
August 13, 2014Research and Development, Sales and Marketing 23andME, Crohn’s disease, Pfizer, google, ulcerative colitis
Pfizer and genetics testing firm 23andMe have come together in a research pact aimed at finding the genetic cause of …
Sanofi signs $925 million inhaled insulin deal
August 13, 2014Sales and Marketing Afrezza, French, Sanofi, diabetes, fad, insulin
Sanofi could pay out as much as $925 million for global rights to the world’s only approved inhaled insulin just …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
